In technical and literal terms, nano-biotechnology means miniaturized biotechnology and refers to ways in which nanotechnology is used to develop devices that can study biological systems and help advance the goals of biology. Even though nano-biotechnology is still in its infancy, scientists and researchers believe that there are several promising methods that will, in the future, rely on nano-biotechnology, giving market experts the hope that this field will yield positive results.
The research report evaluates the structure, elements, scope, and dynamics of the nano-biotechnology market by studying the clinical applications of the field, the mechanisms and devices used, and the therapeutic efficacy that can be achieved from clinical intervention using nano-biotechnology.
Download exclusive Sample of this report:
With the help of market research and technology analysts, the report focuses on providing a comprehensive overview of the nano-biotechnology market, highlighting factors that accelerate the growth of the industry, key players and their business models, trends and technologies that impact the landscape of the nano-biotechnology market, and corporate strategies and recommendations to improve performance.
Overview of the Nano-biotechnology Market
Nano-biotechnology, a unique fusion of biotechnology and nanotechnology, finds application in several clinical areas such as target-specific drug delivery, gene therapy, disease diagnosis, molecular imaging, biosensors, and biomarkers. Given the rising number of new and promising products that are presently undergoing clinical trials, scientists are positive that nano-biotechnology will transform the diagnosis, treatment, and prevention of numerous diseases in the future. Apart from medicine, nano-biotechnology is also potentially useful in the field of biomaterials, electronics, and energy production.
The growing applications of nano-biotechnology and the investments by private and public players indicate that the day is not far when products that are presently being tested in government and academic laboratories will find a commercial platform.
View exclusive Global strategic Business report :
Like any new technology, there are a number of challenges that nano-biotechnology faces, the primary ones being issues concerning the environmental impact and toxicity of nanomaterials and their effect on the global economy. Other challenges the market faces include the development of proper instruments, development of systems to evaluate the impact of nanomaterials on human health and the environment, uncertainty of effectiveness, funding, scalability, and scarce resources.
Companies Mentioned in the Report
The number of companies investing in nano-biotechnology has been on the rise, given the potential this field possesses for advancing medical science and consequently improving healthcare practices across the globe. Some of the players operating in the nano-biotechnology market are Bio Delivery Sciences International (USA), INanoBio (USA), bioMérieux (France), BioNano Genomics (USA), Marina Biotech (USA), Abraxis (USA), Precision NanoSystems (Canada), BioSpectrum (South Korea), WaveSense (USA), Cellix (Ireland), Xantec Bioanalytics (Germany), Dabur Pharma (India), dermaCM (USA), AC Serendip (Germany), and Ablynx (Belgium).